-
Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases
- Julajak Limsrivilai
 , Nonthalee Pausawasdi
-
Intest Res. 2021;19(1):21-32.
-
Review
Epub April 22, 2020
|
-
Use of thiopurines in inflammatory bowel disease: an update
- Arshdeep Singh
 , Ramit Mahajan, Saurabh Kedia, et al.
-
Intest Res. 2022;20(1):11-30.
-
Review
Epub April 15, 2021
|
-
Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
- Ajit Sood, Kirandeep Kaur, Ramit Mahajan, et al.
-
Intest Res. 2021;19(2):206-216.
-
Original Article
Epub July 13, 2020
|
-
Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
- Shin Ju Oh
 , Ga Young Shin, Hosim Soh, et al.
-
Intest Res. 2021;19(3):323-331.
-
Original Article
Epub August 18, 2020
|
-
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
- Choon Jin Ooi
 , Ida Normiha Hilmi , Hyo-Jong Kim, et al.
-
Intest Res. 2021;19(1):71-82.
-
Original Article
Epub September 4, 2020
|
-
Management of inflammatory bowel disease in the COVID-19 era
- Kyeong Ok Kim, Byung Ik Jang
-
Intest Res. 2022;20(1):3-10.
-
Review
Epub February 3, 2021
|
-
The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
- Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, et al.
-
Intest Res. 2021;19(1):62-70.
-
Original Article
Epub May 8, 2020
|
-
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
- Ashish Agarwal, Alka Singh, Wajiha Mehtab, et al.
-
Intest Res. 2021;19(1):106-114.
-
Original Article
Epub April 22, 2020
|
-
Management of Clostridioides difficile infection in patients with inflammatory bowel disease
- Sahil Khanna
-
Intest Res. 2021;19(3):265-274.
-
Review
Epub August 18, 2020
|
-
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
- Yasuo Suzuki
 , Takashi Hagiwara, Mariko Kobayashi, et al.
-
Intest Res. 2021;19(3):301-312.
-
Original Article
Epub August 20, 2020
|
-
Natural history of inflammatory bowel disease: a comparison between the East and the West
- Eun Mi Song, Suk-Kyun Yang
-
Intest Res. 2022;20(4):418-430.
-
Review
Epub December 2, 2021
|
-
Quality of life in inflammatory bowel diseases: it is not all about the bowel
- Ronald Keller
 , Nazar Mazurak, Laura Fantasia, et al.
-
Intest Res. 2021;19(1):45-52.
-
Original Article
Epub February 27, 2020
|
-
Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
- Toshifumi Hibi, Isao Kamae, Philippe Pinton, et al.
-
Intest Res. 2021;19(1):53-61.
-
Original Article
Epub April 22, 2020
|
-
Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018
- Satimai Aniwan, Julajak Limsrivilai, Supot Pongprasobchai, et al.
-
Intest Res. 2021;19(2):186-193.
-
Original Article
Epub August 18, 2020
|
-
Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
- Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, et al.
-
Intest Res. 2021;19(2):127-157.
-
Statement
Epub October 13, 2020
|
-
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment
- Shintaro Akiyama, Victoria Rai, David T. Rubin
-
Intest Res. 2021;19(1):1-11.
-
Review
Epub November 5, 2020
|
-
An overview of the gut side of the SARS-CoV-2 infection
- Bruna Barbosa da Luz
 , Natalia Mulinari Turin de Oliveira, Isabella Wzorek França dos Santos, et al.
-
Intest Res. 2021;19(4):379-385.
-
Review
Epub November 6, 2020
|
-
Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
- Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, et al.
-
Intest Res. 2021;19(1):83-94.
-
Original Article
Epub December 31, 2020
|
-
Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
- Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, et al.
-
Intest Res. 2021;19(1):95-105.
-
Original Article
Epub July 10, 2020
|
-
Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
- Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, et al.
-
Intest Res. 2021;19(4):419-429.
-
Original Article
Epub November 10, 2020
|
-
Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
- Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, et al.
-
Intest Res. 2021;19(4):386-397.
-
Original Article
Epub December 1, 2020
|
-
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
- Sang Hoon Kim, Yun Jeong Lim
-
Intest Res. 2022;20(1):31-42.
-
Review
Epub May 21, 2021
|
-
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
- Sang Hyoung Park
-
Intest Res. 2022;20(2):159-164.
-
Review
Epub April 29, 2022
|
-
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
- Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, et al.
-
Intest Res. 2021;19(4):408-418.
-
Original Article
Epub November 20, 2020
|
-
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
- Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, et al.
-
Intest Res. 2021;19(2):171-185.
-
Review
Epub February 3, 2021
|
-
Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
- Ritika Rampal, Saurabh Kedia, Mohamad Nahidul Wari, et al.
-
Intest Res. 2021;19(2):232-238.
-
Original Article
Epub May 8, 2020
|
-
Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
- Sanchit Sharma, Arti Gupta, Saurabh Kedia, et al.
-
Intest Res. 2021;19(3):291-300.
-
Original Article
Epub May 26, 2020
|
-
Trends of inflammatory bowel disease at a tertiary care center in northern India
- Ajit Sood, Kirandeep Kaur, Arshdeep Singh, et al.
-
Intest Res. 2021;19(3):282-290.
-
Original Article
Epub August 18, 2020
|
-
Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways
- Maged E. Mohamed
 , Sahar A. Elsayed, Hafez R. Madkor, et al.
-
Intest Res. 2021;19(2):194-205.
-
Original Article
Epub August 21, 2020
|
-
Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
- Rupa Banerjee, Partha Pal, Zaheer Nabi, et al.
-
Intest Res. 2021;19(4):398-407.
-
Original Article
Epub November 20, 2020
|
